ArticleDiabetes2022

Impaired Glucagon-Mediated Suppression of VLDL-Triglyceride Secretion in Individuals With Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD).

Sara Heebøll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.